More Botanix Pharmaceuticals Limited news
Botanix Pharmaceuticals LimitedASX: BOT

S&P DJI Announces March 2025 Quarterly Rebalance

Mar 7, 2025 at 6:22 AM EST · Issued by Botanix Pharmaceuticals Limited

Filed with ASX · Mar 7, 2025 at 6:22 AM EST · 8 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2025-quarterly-rebalance-64

Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2↗

Botanix Pharmaceuticals Limited on 6ix

Story so far

  • S&P DJI Announces March 2024 Quarterly RebalanceMar 1, 2024

Earlier from Botanix Pharmaceuticals

  • December 2024 Quarterly Activities Report and Appendix 4CJan 30, 2025
  • First Sofdra Prescriptions as Commercialisation Ramps UpDec 16, 2024
  • Botanix Pharmaceuticals: Releases Quarterly ReportsOct 28, 2024
  • September 2024 Quarterly Activities Report and Appendix 4COct 27, 2024
  • Botanix Appendix 4E & Announcement of Commercial Day WebinarAug 30, 2024

Later from Botanix Pharmaceuticals

  • Botanix Conference Commercial UpdateMar 10, 2025
  • Botanix $40 Million Capital Raising for Sofdra RolloutApr 15, 2025
  • March 2025 Quarterly Activities Report and Appendix 4CApr 24, 2025
  • Pause in tradingMay 12, 2025
  • Botanix Responds to US Pharmaceutical Pricing AnnouncementMay 12, 2025
All Botanix Pharmaceuticals news releases↗

Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.

Follow Botanix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer